Skip to content

Olive Oil With Omega 3 to Treat Stasis Dermatitis

Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00421161
Enrollment
30
Registered
2007-01-11
Start date
2007-01-31
Completion date
2007-03-31
Last updated
2007-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis

Keywords

olive oil, stasis dermatitis, Patients with stasis dermatitis for at least six months.

Brief summary

Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.

Detailed description

Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use Venoroutone . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.

Interventions

DRUGolive oil and omega 3 in a combined cream

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patints with stasis dermatitis for 6 months at least

Exclusion criteria

* skin ulceration or infection

Design outcomes

Primary

MeasureTime frame
improvement in subjective and objective skin changes of patient: pain, edema, redness, size of involement,

Countries

Israel

Contacts

Primary ContactRefael Segal, MD, Prof'
rsegal@post.tau.ac.il972-8-9258640-3
Backup ContactArie Bas, MD, Prof
arbas@post.tau.ac.il972-8-9779188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026